Le Lézard
Classified in: Health, Business
Subject: PER

International Medical Group Appoints Steve Paraboschi as Executive Vice President



INDIANAPOLIS, Oct. 5, 2017 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning international medical and travel insurance company, is pleased to announce that Steve Paraboschi has joined the company as executive vice president.

International Medical Group (IMG) is an award-winning international medical and travel insurance company.

Paraboschi will be responsible for P&L across the company and support of IMG's international insurance distribution and operations.

"IMG is a market leader whose rapid global growth, innovative product solutions and steadfast commitment to being there for its customers set it apart from competitors," Paraboschi said. "I'm thrilled to join IMG at such an exciting time in the company's history, and look forward to working with its outstanding leadership team to further the company's international reputation for excellence."

Paraboschi comes to IMG from AXA Assistance USA, where he served as the chief executive officer, managing a profitable P&L, driving alignment and global strategies, and developing innovative product distribution methods.

Previously, as the general manager and vice president of AXA Assistance USA's Global Healthcare TPA and Travel Services business, Paraboschi spearheaded the development of a travel risk management product, directed successful market entries, improved bottom line performance, and led revenue growth of 110% over five years.

Prior to his time at AXA, Paraboschi worked at The Guardian Life Insurance Company and MetLife. He currently serves on the Board of Directors for the U.S. Travel Insurance Association and the French American Chamber of Commerce of Chicago.

"We are pleased to welcome Steve to the IMG team," said President and CEO Brian Barwick. "He has a proven track record of developing business strategies that drive top line and bottom line growth, while supporting a dynamic environment of teamwork and employee development. His customer-focused and results-oriented approach, combined with his industry expertise, make him distinctly qualified to serve as IMG's executive vice president."

About International Medical Group
International Medical Group® (IMG®), a Sirius Group company, is an award-winning international medical and travel insurance company that has served millions of members worldwide since its founding in 1990. A leader in the global benefits and assistance services industry, IMG offers a full line of international medical insurance products, as well as travel insurance plans, medical management services and 24/7 emergency medical and travel assistance. For more information, please visit www.imglobal.com.

Logo - http://mma.prnewswire.com/media/564172/IMG_Logo_2016_TM_Logo.jpg 


These press releases may also interest you

at 13:00
Orig3n, a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine, today announced that its co-founders, Robin Y. Smith, CEO, and Kate Blanchard, COO, are finalists for the Ernest and Young Entrepreneur...

at 13:00
The "Infantile Spasms Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global infantile spasms therapeutics market to...

at 13:00
Members of the Union of Canadian Correctional Officers (UCCO-SACC-CSN) will be demonstrating on Monday, June 25, in front of the office of Ginette Petitpas Taylor, Canada's Minister of Health. The correctional officers are asking the government to...

at 13:00
Mezzion Pharma and the National Heart, Lung, and Blood Institute (NHLBI) today announced that it has completed enrollment of their FUEL trial, a pivotal Phase 3 efficacy and safety trial of udenafil for the treatment of adolescents with congenital...

at 12:51
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism. This is the...

at 12:47
FSD Pharma Inc. ("FSD" or the "Company") , welcomes the official passing of Bill C-45, the Cannabis Act in Canada. Bill C-45 formally received Royal Assent Thursday morning in Canada's Parliament. The bill officially...




News published on 5 october 2017 at 10:00 and distributed by: